Part Details | USP DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION
6505-01-103-8583
Alternate Parts: RENOCAL76, RENOCAL-76, NDC00270086020, NDC00270-0860-20, 030069, 03-0069, NDC00407077604, NDC00407-0776-04, HYPAQUE76, HYPAQUE-76, NDC00407077604, NDC00407-0776-04, HYPAQUE76, HYPAQUE-76, 6505-01-103-8583, 01-103-8583, 6505011038583, 011038583
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | NOV 21, 1980 | 01-103-8583 | 32823 ( DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-103-8583
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| RENOCAL-76 | 05HX5 | BRACCO DIAGNOSTICS INC |
| NDC00270-0860-20 | 05HX5 | BRACCO DIAGNOSTICS INC |
| 03-0069 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC00407-0776-04 | 0AY96 | GE HEALTHCARE INC. |
| HYPAQUE-76 | 0AY96 | GE HEALTHCARE INC. |
| NDC00407-0776-04 | 63240 | SANOFI-SYNTHELABO INC |
| HYPAQUE-76 | 63240 | SANOFI-SYNTHELABO INC |
Technical Data | NSN 6505-01-103-8583
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB66.000 PERCENTAGE, W/V AND AB10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM |
| PHARMACEUTICAL VEHICLE TYPE | B ANY ACCEPTABLE |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| PROTECTIVE STORAGE FEATURE | |
| SUPPLEMENTARY FEATURES | 76% SOLUTION; CONTAINS 4.48 MG SODIUM PER ML; RADIOPAQUE MEDIUM USED IN UROGRAPHY |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DIATRIZOATE MEGLUMINE & DIATRIZOATE SODIUM INJ USP 50ML 25S VI |